Mobia Medical, Inc.(MOBI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
MOBI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Mobia Medical, Inc. (MOBI), a Healthcare sector company. MOBI is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), Mobia Medical, Inc. reports quarterly revenue of $12.1M, net income of $-17.7M, free cash flow of $-17.8M. MOBI trades on the Nasdaq exchange and files with the SEC under CIK 1489993. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MOBI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Mobia Medical, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$12.1M
Net Income
Q1 2026
$-17.7M
Free Cash Flow
Q1 2026
$-17.8M
AI Insight: MOBI Financial Trends
Mobia Medical is burning cash with negative operating income and operating cash flow; equity position severely eroded.
• Revenue of $12M in Q1 2026, but operating income and operating cash flow both negative at -$17M and -$18M respectively.
• Stockholders' equity turned deeply negative at -$168M, indicating liabilities exceed assets by a significant margin.
⚠ Cash burn rate ($18M operating cash outflow on $12M revenue) unsustainable without capital infusion or path to profitability.
⚠ Negative equity signals balance sheet stress; refinancing risk and potential shareholder dilution ahead.
AI Insight: MOBI Ratio Trends
Mobia Medical posted a catastrophic Q1 2026 with -140.3% operating margin and -146.9% net profit margin, signaling severe operational distress.
• Operating margin collapsed to -140.3% in Q1 2026, indicating massive operating losses relative to revenue.
• Net profit margin of -146.9% in Q1 2026 shows net losses exceed total revenue.
• ROA fell to -96.4% in Q1 2026, reflecting severe asset base deterioration or extraordinary losses.
⚠ Single-quarter snapshot with no historical context; unclear whether losses are seasonal or structural.
⚠ Debt-to-equity and ROIC unavailable; balance sheet and leverage status unknown during distress.
Get alerted when MOBI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Mobia Medical, Inc. including:
More Healthcare Companies
View all Healthcare →Put MOBI on your watchlist
Track score changes the day Mobia Medical, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MOBI a good stock to buy?
13F Pro's AI-powered analysis of Mobia Medical, Inc. (MOBI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MOBI are available on the MOBI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own MOBI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MOBI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Mobia Medical, Inc.'s investment landscape.